Trials / Unknown
UnknownNCT04918875
Oxygen Requirements and Use in Patients With COVID-19 in LMICs
Oxygen Requirements and Approaches to Respiratory Support in Patients With COVID-19 in LMICs: A WHO Study
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,400 (estimated)
- Sponsor
- Pryanka Relan · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
This observational cohort study will enroll patients in LMICs with suspected or confirmed COVID-19 on oxygen or deemed to require oxygen therapy based on objective criteria. Demographics and risk factor information will be collected from participants. Participants will be followed for 7 days or until outcome (hospital discharge or death). Facility level metrics on oxygen availability will also be collected at the beginning of site enrolment.
Detailed description
The COVID-19 pandemic has highlighted, more than ever, the acute need for scale up of oxygen therapy. WHO has provided an inventory tool to quantify facility-level provision of infrastructure to deliver oxygen therapy. However, data on the use of oxygen therapy at the patient-level remains lacking. This observational cohort study will enroll patients in LMICs with suspected or confirmed COVID-19 on oxygen or deemed to require oxygen therapy based on objective criteria. Demographics and risk factor information will be collected from participants. Participants will be followed for 7 days or until outcome (hospital discharge or death). Facility level metrics on oxygen availability will also be collected at the beginning of site enrolment.
Conditions
Timeline
- Start date
- 2022-01-01
- Primary completion
- 2023-04-30
- Completion
- 2023-10-30
- First posted
- 2021-06-09
- Last updated
- 2023-08-23
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04918875. Inclusion in this directory is not an endorsement.